Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty | MicrobiomeTrials← Back to trialsNCT06926933
Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2024-12-12Est. Completion: 2026-06-15
Enrollment target: 50 participants Locations- Korea University Ansan Hospital, Ansan, South Korea
- Jeonbuk National University Hospital, Jeonju, South Korea
- Chosun University Hospital, Kwangju, South Korea
- Seoul National University Bundang Hospital, Seongnam, South Korea
- Asan Medical Center, Seoul, South Korea
- Gangnam Severance Hospital, Seoul, South Korea
- Kangdong Sacred Heart Hospital, Seoul, South Korea
- Kyung Hee University Hospital At Gangdong, Seoul, South Korea
- Ajou University Medical Center, Suwon, South Korea
Other microbiome trials you might be interested in
Genetic DisorderInfertilityHypogonadismAmenorrhea
Background:
\- During puberty, children begin to develop into adults. Problems with the hormones released during pubert…
Bethesda, United States
Early Childhood Caries (ECC)Color Stability of RestorationCaries ArrestedCaries,Dental
Early childhood caries is a serious public health issue often neglected and goes untreated having detrimental effects on…
Jizan, Saudi Arabia
Completed Jun 2, 2025
EndometriosisChronic Pelvic Pain
This study will examine pelvic pain associated with endometriosis and explore better approaches to treatment. In women w…
Bethesda, United States